Author Archives: Lu Rahman

#Drug discovery

DDW at Drug Discovery Digital

Drug Discovery World, the multi-platform global voice for the drug discovery community will be at ELRIG Drug Discovery Digital from 6-16 October 2020. Head to stand P3 to tell us about your news and innovation – we are always pleased to find out the latest breakthroughs in the global… Read More

#News

#Drug discovery #ELRIG

Drug Discovery Digital now open

ELRIG’s Drug Discovery Digital has begun. In addition to world-class scientific talks, a bustling virtual exhibition provides the opportunity to connect directly with experts to hear about the latest technologies that could aid your research efforts. You’ll also be able to pick up a few tips and tricks you… Read More

#News

#Diamond Pharma Services #EMA #Gene therapy #Marketing approval authorisation

Diamond Pharma Services supports MAA for ocular gene therapy

Diamond Pharma Services has provided EU regulatory, pharmacovigilance, quality and compliance support to GenSight Biologics including the preparation, authoring support, agency communication and submission of GenSight’s first marketing authorisation application (MAA) to the European Medicines Agency (EMA), for its novel ocular gene therapy LUMEVOQ.  The EMA decision is expected in… Read More

#News

#Cell therapy #Gene therapy

Analytical thinking: a focus on cell & gene therapeutic analysis

Absorption Systems works collaboratively with biotech and pharma companies. Dealing with their future therapeutics, the company’s analytical research services help customers streamline and simplify the approval process. Lu Rahman found out more from CEO Patrick Dentinger. LR: Describe Absorption Systems’ analytical testing expertise in relation to cell and gene therapy… Read More

#Exclusive Content

#Cobra Biologics #Covid-19 #Scancell Holdings #Vaccines

Cobra Biologics to manufacture plasmids for Phase I clinical trial COVID-19 vaccine

Cobra Biologics is to manufacture Scancell Holdings COVID-19 vaccine. The agreement covers Good Manufacturing Practice (GMP) production of plasmid DNA needed to generate the DNA vaccine, against SARS-CoV-2, for use in a Phase I clinical trial in 2021 (COVIDITY). The project is funded by an Innovate UK grant awarded to… Read More

#Covid-19 #News

#AI / data analytics / healthtech / informatics #Novartis

Stop, collaborate and listen: a model for successful pharma and vendor engagement

Digital transformations are having wide-ranging and profound impacts within life sciences, creating both opportunities and challenges. One of those challenges is adopting new software systems to drive the transformations. Pharma invests in powerful software technologies with the promise of increased efficiencies, but ultimately, if the interfaces are unintuitive and more… Read More

#Exclusive Content

#CAR-T #Sartorius #Webinar

Event provides insight for researchers into BiTE antibodies and CAR-T cells

If you are a biotech scientist interested in reversing or overcoming the state of T-cell exhaustion, this webinar will be of interest. Quantifying T cell exhaustion: An insight into BiTE antibodies and CAR-T cells for improved therapeutics will be hosted by DDW and presented by Sartorius. It will examine T cell… Read More

#News

#AI / data analytics / healthtech / informatics #Clinical trials #Covid-19

Sector professionals believe COVID-19 must trigger a change in clinical trials

As a consequence of the coronavirus pandemic, 41% of global clinical trials in fields other than COVID-19 (c.4,5001) have been delayed or put on permanent hold. Looking ahead, 74% of life science organisations say that COVID-19 will continue to compromise their ability to deliver on clinical trial objectives for the… Read More

#News

#Adeptrix #Assay development & optimisation #Avacta #Covid-19

Avacta launches BAMS assay to detect SARS-CoV-2 research test

Avacta’s BAMS assay to detect the SARS-CoV-2 virus has been launched as a research kit by its partner Adeptrix and the assay has been presented by Bruker Scientific, a mass spectrometer manufacturer, in a new application note. The bead-assisted mass spectrometry (BAMS) assay uses the Affimer reagents specific to the… Read More

#Covid-19 #News

#Bioproduction #Cell therapy #CPhI #Gene therapy

Report spots cell & gene therapy capacity shortages in the USA

CPhI Annual Report 2020 highlights cell and gene therapy capacity shortages in the USA and 10+ mAb approvals in China. Continuous Bioprocessing growing quickly, but from a low base, with virtually all manufacturers now using at least some single use technologies. CPhI Annual Report – launched ahead of the… Read More

#News

#Covid-19 #Immunology / Virology & Vaccines

Survey finds three in ten Americans unwilling to have COVID vaccine

Almost seven in 10 Americans would be interested in receiving a COVID-19 vaccine, a study finds. But researchers say there are concerning gaps in interest, particularly among Black Americans, who suffer disproportionately from the virus. Researchers from The Ohio State University surveyed more than 2,000 Americans, asking them about their… Read More

#Covid-19 #News #Trending News

#Institute of Cancer Research #Oncology #Precision medicine

Combining precision medicines can treat drug-resistant cancers

Launching a dual-pronged attack on tumours using a combination of two innovative precision medicines could treat patients with multiple common cancers, a new clinical trial shows. It is the first trial to use the pioneering genetically targeted drug olaparib – already licensed for ovarian, breast and prostate cancer – together… Read More

#Trending News

#Analytica #ELRIG #Events #SLAS

Drug discovery industry event update and COVID-19

Despite causing huge global upheaval, COVID-19 hasn’t deterred the drug discovery and development events sector. Throughout the pandemic, event organisers have been working to ensure that the relationship building, knowledge and innovation we rely on events to deliver, can still happen despite the restrictions. SLAS 2021 January 25-27 There are… Read More

#News

#Metabolomics #Metabolon

Metabolon announces $72 million financing to boost drug development

Metabolon, has announced the close on $72 million in combined debt and equity financing. This round of financing included Perceptive Advisors as a new participant. EW Healthcare Partners and other existing investors also participated in the financing. “We are thrilled by this strong show of support from Perceptive Advisors and… Read More

#News

#Cell therapy #Gene therapy #ISCT

ISCT in focus

The International Society for Cell & Gene Therapy (ISCT) has a vision - to translate cell and gene research into safe and effective therapies to improve patients’ lives worldwide. Queenie Jang, CEO, explains…. Established in 1992, the ISCT  is a global society of over 2300 clinicians, regulators, researchers, technologists and industry… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Alzheimer's #Biomarkers #iLoF

The start-up that knows one size doesn’t fit all

Luis Valente, CEO & Co-Founder of iLoF, has been recognized by Forbes as one of the top 30 under 30 for science and healthcare. He told Lu Rahman what’s behind his start-up that recently secured $1 million in investment from Microsoft’s Venture Fund, M12 and Mayfield Fund and won the… Read More

#Start-up Zone